Effects of Carvedilol Compared to Nebivolol on Insulin Resistance and Lipid Profile in Patients With Essential Hypertension

The Effect of Low-Dose Carvedilol, Nebivolol, and Metoprolol on Central Arterial Pressure and Its Determinants: A Randomized Clinical Trial

(2013) Péter Studinger et al.   Journal of Clinical Hypertension

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study

(2010) Britt Kveiborg et al.   Cardiovascular Diabetology

Hypertension, Dyslipidemia, and Insulin Resistance in Patients With Diabetes Mellitus or the Cardiometabolic Syndrome: Benefits of Vasodilating β-Blockers

(2010) Prakash Deedwania   Journal of Clinical Hypertension

HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)

(2009) Bruno Geloneze et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

P0600 CARVEDILOL OR NEBIVOLOL: WHICH ONE IS EFFECTIVE ON INSULIN RESISTANCE?

(2009) Mehmet Yildiz et al.   European Journal of Internal Medicine

Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial

(2009) Gregg C. Fonarow et al.   Journal of the American Society of Hypertension

β-Blockers in the Treatment of Hypertension: New Data, New Directions

(2008) Michael A. Weber et al.   Journal of Clinical Hypertension